Latest News about ENVB
Recent news which mentions ENVB
From Benzinga
From Benzinga
From Benzinga
From Benzinga
Dow Dips Over 100 Points; TJX Earnings Top Views
February 26, 2025
From Benzinga
Nasdaq Surges 150 Points; Lowe's Posts Upbeat Earnings
February 26, 2025
From Benzinga
US Stocks Likely To Open Higher Ahead Of Nvidia Earnings: S&P 500's Four-Day Fall Was A 'Non-Event,' Says Expert
February 26, 2025
From Benzinga
Why ZoomInfo Technologies Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket
February 26, 2025
From Benzinga
EXCLUSIVE: Non-Hallucinogenic Psychedelic Compounds Show Promise For Treating Addiction And ADHD
February 25, 2025
From Benzinga
Enveric Biosciences Inks Two Licensing Agreements With Restoration Biologics To Treat Joint Disease
February 04, 2025
From Benzinga
Dow Edges Lower; Exxon Mobil Earnings Top Views
January 31, 2025
From Benzinga
Nasdaq Jumps Over 150 Points; Apple Posts Upbeat Earnings
January 31, 2025
From Benzinga
From Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
January 07, 2025
From Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
November 27, 2024
From Benzinga
Enveric Biosciences Advances Non-Hallucinogenic DMT Analog Drug With Promising Preclinical Results
November 25, 2024
From Benzinga
Why Symbotic Shares Are Trading Higher By Over 28%; Here Are 20 Stocks Moving Premarket
November 19, 2024
From Benzinga
Enveric Biosciences Trims Losses, Eyes Key Drug Approval For Difficult-To-Treat Mental Health Disorders
November 18, 2024
From Benzinga
Enveric Biosciences Out-Licenses Key Program To MycoMedica In $62M Deal
November 12, 2024
From Benzinga
From Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
October 23, 2024
From Benzinga
From Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
October 15, 2024
From Benzinga
Psychedelics 2.0: Companies Explore Safer, More Targeted Therapies
October 04, 2024
From Benzinga
Non-Hallucinogenic Psychedelic Treatment For Anxiety And Depression In Pre-Clinical Models: Enveric Biosciences' Breakthrough Research
September 25, 2024
From Benzinga
ENVB Stock Earnings: Enveric Biosciences Beats EPS for Q2 2024
August 12, 2024
Tickers
ENVB
From InvestorPlace
Why Merck Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
July 30, 2024
From Benzinga
Why Is Imunon (IMNN) Stock Up 259% Today?
July 30, 2024
From InvestorPlace
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.